Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02835443 · ClinicalTrials.gov registry record · NA

Electrical Stimulation of the Dentate Nucleus for Upper Extremity Hemiparesis Due to Ischemic Stroke

A NA study, sponsored by Enspire DBS Therapy.

Completed
Registry status
NA
Development phase
12
Enrollment target

NCT02835443: Completed NA study, sponsored by Enspire DBS Therapy.

NCT02835443 is a NA study that has completed, run by Enspire DBS Therapy. The registered enrollment target is 12 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02835443, a NA study, has completed, sponsored by Enspire DBS Therapy.

COMPLETED
Registry status
NA
Development phase
12 participants
Enrollment target

Study Summary

This clinical trial will evaluate if Deep Brain Stimulation (DBS) is safe for the treatment of stroke and will help understand if DBS improves motor recovery for patients who continue to have significant impairment.

Primary Outcome

Incidence of study-related serious adverse events

Interventions

  • DEVICE Deep Brain Stimulation

Trial Details

FieldValue
Enrollment Target 12 participants
Start Date 2016-10-26
Est. Completion 2023-01
Phase NA
Enspire DBS Therapy

2 total trials

What the finished NCT02835443 record still lists

NCT02835443 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 12 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 1 intervention - of which Deep Brain Stimulation is the first listed.

NCT02835443 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02835443 about?

NCT02835443 is a clinical study titled "Electrical Stimulation of the Dentate Nucleus for Upper Extremity Hemiparesis Due to Ischemic Stroke". This clinical trial will evaluate if Deep Brain Stimulation (DBS) is safe for the treatment of stroke and will help understand if DBS improves motor recovery for patients who continue to have significant impairment.

What is the current status of trial NCT02835443?

This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2016-10-26. Estimated completion is 2023-01.

What interventions are being tested in trial NCT02835443?

The interventions under investigation include: Deep Brain Stimulation (DEVICE).

Who is sponsoring clinical trial NCT02835443?

This trial is sponsored by Enspire DBS Therapy, which has 2 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02835443's enrollment target sits among peer trials

12 1913th of 2000 higher than 74 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02602769 · 12 participants

    Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome

  • NCT02605421 · 12 participants · Phase 2

    Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma

  • NCT02619448 · 12 participants · Early Phase 1

    Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC

  • NCT03311503 · 12 participants · Phase 1

    Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT02835443, the US trial registry maintained by the National Library of Medicine. NCT02835443 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.